Pasithea Therapeutics (KTTA) Divestments (2022 - 2023)
Pasithea Therapeutics recorded quarterly Divestments of $319618.0 in Q2 2023, up 7529.94% quarter-over-quarter from $4189.0 in Q1 2023, and up 173.94% year-over-year from $116676.2 in Q2 2022.
Pasithea Therapeutics' Divestments history runs 2 years deep, the most recent figure standing at $319618.0 for Q2 2023.
- In Q2 2023, Divestments rose 173.94% year-over-year to $319618.0; the TTM figure through Dec 2023 stood at $323807.0 (up 151.65% YoY), while the FY2023 annual figure was $323807.0, up 151.65% from the prior year.
- Divestments came in at $319618.0 for Q2 2023 at Pasithea Therapeutics, up from $4189.0 in the prior quarter.
- In the past five years, Divestments ranged from a high of $319618.0 in Q2 2023 to a low of -$432291.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 319,618.00 |
| Mar 31, 2023 | 4,189.00 |
| Dec 31, 2022 | 71,892.00 |
| Sep 30, 2022 | -159,955.00 |
| Jun 30, 2022 | -432,291.00 |
| Mar 31, 2022 | -106,544.00 |